16
Participants
Start Date
August 31, 2000
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
non-myeloablative hematopoietic cell transplantation
TLI and ATG infusion of the donor graft Post-transplant immunosuppression with cyclosporine and mycophenolate mofetil.
Anti-Thymocyte Globulin
1.5 mg/kg QD x 5, IV. Dosage will be based on body weight. Purified, sterile IgG fraction of immune serum of rabbits immumixied with human thymus lymphocyte. This drug acts to modify the number and function of lymphocytes.
Cyclosporine
6.25 mg/kg BID, PO.Mechanism of action is inhibition of T-cell activation by binding to a cytoplasmic protein (cyclophillin).
Mycophenolate Mofetil
15 mg/kg Q 8 hours, PO. Inhibtis the enzme inosine monophsophate dehydrogenase (MPDII) noncompetitively which blocks the de nobo synthesis of guanosine required for DNA synthesis and has an effect on T and B cells.
G-CSF
16 mg/kg, SQ Growth factor used to make bone marrow produce more blood cells
Solumedrol
1.0 mg/kg IV 2 hours prior to ATG Used to treat severe inflamation
Acetaminophen
650 mg PO, 30 minutes prior to infusion Pain reliever
Diphenydramine
50 mg IV, 30 minutes prior to infusion Used to relieve allergy symptoms
Hydrocortisone
100 mg IV, 1 hour prior to infusion Used to relieve itching, redness and swelling of the skin
Stanford University School of Medicine, Stanford
Stanford University
OTHER